top of page
연구-이미지1.jpg

R&D

Research and Development 

R&D

Stealth-Body

항체원천기술은 질환세포에만

선택적으로 약물을 전달할 수 있음

CPP-001 (Protein delivery)

CPS-001 (Small molecule delivery)

CPR-001 (Gene delivery) 

Smart Cell Targeting

Stealth-Body

antibody
  • Proprietary mutations for reduced Fc-effector functions.

  • CrossPoint’s Stealth-Body shows no binding or activity above background across Fc gamma receptors, far surpassing all previously described modifications.

  • CrossPoint’s Stealth-Body limits off-target toxicity issues for the development of next-generation antibody therapies.

연구-이미지3_edited.jpg
delivery protein

Protein delivery

delivery small molecule

Small molecule delivery

delivery gene

Gene delivery

bispecific antibody
ADC
Gene delivery antibody

-Dual targeting

-No Fc effector function

-Natural ligand

-Immune modulation
-No Fc effector function

-RNA regulation

-Tissue & Cell Specificity

a

R&D

Pipeline

Project code, Target, Indication,

Discovery, Preclinical

pipeline
p
bottom of page